These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 24346918

  • 1. Systemic sarcoidosis induced by etanercept: first Brazilian case report.
    Unterstell N, Bressan AL, Serpa LA, Fonseca e Castro PP, Gripp AC.
    An Bras Dermatol; 2013; 88(6 Suppl 1):197-9. PubMed ID: 24346918
    [Abstract] [Full Text] [Related]

  • 2. Development of exclusively cutaneous sarcoidosis in patient with rheumatoid arthritis during treatment with etanercept.
    Vieira MA, Saraiva MI, Silva LK, Fraga RC, Kakizaki P, Valente NY.
    Rev Assoc Med Bras (1992); 2016 Nov; 62(8):718-720. PubMed ID: 27992009
    [Abstract] [Full Text] [Related]

  • 3. Uveitis associated with sarcoidosis exacerbated by etanercept therapy.
    Suzuki J, Goto H.
    Jpn J Ophthalmol; 2009 Jul; 53(4):439-40. PubMed ID: 19763766
    [No Abstract] [Full Text] [Related]

  • 4. Sarcoidosis: an underestimated and potentially severe side effect of anti-TNF-alpha therapy.
    Vigne C, Tebib JG, Pacheco Y, Coury F.
    Joint Bone Spine; 2013 Jan; 80(1):104-7. PubMed ID: 22885144
    [No Abstract] [Full Text] [Related]

  • 5. Development of cutaneous sarcoidosis during treatment with tumour necrosis alpha factor antagonists.
    Lamrock E, Brown P.
    Australas J Dermatol; 2012 Nov; 53(4):e87-90. PubMed ID: 23157794
    [Abstract] [Full Text] [Related]

  • 6. Development of sarcoidosis following etanercept treatment: a report of three cases.
    Skoie IM, Wildhagen K, Omdal R.
    Rheumatol Int; 2012 Apr; 32(4):1049-53. PubMed ID: 20062997
    [Abstract] [Full Text] [Related]

  • 7. Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients.
    Verschueren K, Van Essche E, Verschueren P, Taelman V, Westhovens R.
    Clin Rheumatol; 2007 Nov; 26(11):1969-71. PubMed ID: 17340045
    [Abstract] [Full Text] [Related]

  • 8. New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication.
    Tong D, Manolios N, Howe G, Spencer D.
    Intern Med J; 2012 Jan; 42(1):89-94. PubMed ID: 22389903
    [Abstract] [Full Text] [Related]

  • 9. Development of pulmonary and cardiac sarcoidosis during etanercept therapy.
    Miyagi R, Ideguchi H, Soga T, Yamakawa Y, Otsuki H, Niino H, Shiina T, Ueda A, Ishigatsubo Y.
    Int J Rheum Dis; 2014 Sep; 17(7):810-2. PubMed ID: 24460777
    [No Abstract] [Full Text] [Related]

  • 10. Cutaneous pseudolymphoma associated with a TNF-alpha inhibitor treatment: etanercept.
    Guis S, Schiano de Colella JM, Bonnet N, Andrac-Meyer L, Balandraud N, Mattei JP, Franck B, Roudier C, Roudier J, Berbis P.
    Eur J Dermatol; 2008 Sep; 18(4):474-6. PubMed ID: 18573737
    [No Abstract] [Full Text] [Related]

  • 11. Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases.
    Toussirot E, Pertuiset E, Kantelip B, Wendling D.
    Clin Exp Rheumatol; 2008 Sep; 26(3):471-5. PubMed ID: 18578973
    [Abstract] [Full Text] [Related]

  • 12. Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge.
    van der Stoep D, Braunstahl GJ, van Zeben J, Wouters J.
    J Rheumatol; 2009 Dec; 36(12):2847-8. PubMed ID: 19966199
    [No Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor-alpha antagonist-induced sarcoidosis.
    Clementine RR, Lyman J, Zakem J, Mallepalli J, Lindsey S, Quinet R.
    J Clin Rheumatol; 2010 Sep; 16(6):274-9. PubMed ID: 20808167
    [Abstract] [Full Text] [Related]

  • 14. Abrupt development of sarcoidosis with a prodromal increase in plasma osteopontin in a patient with rheumatoid arthritis during treatment with etanercept.
    Takatori S, Kamata Y, Murosaki T, Iwamoto M, Minota S.
    J Rheumatol; 2010 Jan; 37(1):210-1. PubMed ID: 20040649
    [No Abstract] [Full Text] [Related]

  • 15. Development of sarcoidosis during etanercept therapy.
    Ishiguro T, Takayanagi N, Kurashima K, Matsushita A, Harasawa K, Yoneda K, Tsuchiya N, Miyahara Y, Yamaguchi S, Yano R, Tokunaga D, Saito H, Ubukata M, Yanagisawa T, Sugita Y, Kawabata Y.
    Intern Med; 2008 Jan; 47(11):1021-5. PubMed ID: 18520114
    [Abstract] [Full Text] [Related]

  • 16. Sarcoid panuveitis associated with etanercept treatment, resolving with adalimumab.
    Dragnev D, Barr D, Kulshrestha M, Shanmugalingam S.
    BMJ Case Rep; 2013 Sep 04; 2013():. PubMed ID: 24005973
    [Abstract] [Full Text] [Related]

  • 17. Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review.
    Gifre L, Ruiz-Esquide V, Xaubet A, Gómez-Puerta JA, Hernández MV, Sanmartí R.
    Arch Bronconeumol; 2011 Apr 04; 47(4):208-12. PubMed ID: 20638761
    [Abstract] [Full Text] [Related]

  • 18. Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis.
    Durel CA, Feurer E, Pialat JB, Berthoux E, Chapurlat RD, Confavreux CB.
    BMC Neurol; 2013 Dec 28; 13():212. PubMed ID: 24373564
    [Abstract] [Full Text] [Related]

  • 19. [Severe hypercalcemia revealing sarcoidosis precipitated by etanercept].
    Watrin A, Royer M, Legrand E, Gagnadoux F.
    Rev Mal Respir; 2014 Mar 28; 31(3):255-8. PubMed ID: 24680117
    [Abstract] [Full Text] [Related]

  • 20. Etanercept-induced sarcoidosis presented with scrotal lesion: a rare manifestation in genital area.
    Chaowattanapanit S, Aiempanakit K, Silpa-Archa N.
    J Dermatol; 2014 Mar 28; 41(3):267-8. PubMed ID: 24765664
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.